Home / Markets
Wednesday, January 07, 2009
Wyeth in Talks to Buy Crucell
Associated Press
NEW YORK--Dutch vaccine maker Crucell (CRXL) says it is in acquisition talks with drugmaker Wyeth (WYE). Crucell NV says the talks are at preliminary stages.
The statement comes shortly after a Wall Street Journal report saying Wyeth was in talks to buy Crucell for up to $1.35 billion.
A spokesman for Madison, New Jersey-based Wyeth says the company does not comment on market speculation.
The report, published on the newspaper's Web site Wednesday and attributed to unnamed sources, comes hours after Wyeth Chief
Executive and Chairman Bernard Poussot told analysts at an investment conference that he believes "the only way forward for
the pharmaceutical industry is to get into biotechnology."
Fox Business Video
-
-
The Crisis With 20/20 Hindsight
-
Nov 21, 2009
FOXBusiness.com LIVE
-
-
-
Jerry Rice Talks Career
-
Nov 21, 2009
NFL Receiver on career on the gridiron
-
-
-
John O'Hurley as Venture Capitalist
-
Nov 21, 2009
Comedian on life as venture capitalist
-
-
-
Excess Spending in Congress
-
Nov 21, 2009
Saving $100 Million
-
-
-
Cavuto Business Report 11-20-09
-
Nov 21, 2009
Business Report: Cavuto
-
